Amarin Corp Plc\Uk
AMRN Nasdaq· Pharmaceutical Preparations
Last close · Oct 26, 2026
$12.09
KIRA · Stoqly’s AI analyst, in plain words
- Amarin Corp Plc\Uk had $214M of revenue in fiscal 2025, down 6.5% on the year before. Over five years, revenue changed −19.0% a year on average.
- Its operating margin was −23.5%, up 16.7 pts: of every 100 in sales, about −23 is left after running the business.
- Amarin Corp Plc\Uk lost $38.8M in fiscal 2025.
Market cap
$5.0B
P/E
—
Revenue
$214M
Net income
−$38.8M
Free cash flow
—
Operating margin
−23.5%
Amarin Corp Plc\Uk in 30 seconds · fiscal 2025
Are sales growing?
−6.5%
No. Sales fell 6.5% last year.
Does it make a profit?
−18.2%
No. It lost money last year.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Amarin Corp Plc\Uk does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 2, 2026
- Legal name
- AMARIN CORP PLC\UK
- CIK
- 0000897448
Amarin Corp Plc\Uk · AMRN
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $583M | $369M | $307M | $229M | $214M |
| Revenue growth | −5.0% | −36.7% | −16.9% | −25.5% | −6.5% |
| Gross margin | 79.2% | 65.7% | 53.9% | 35.6% | 56.6% |
| Operating margin | 1.8% | −28.7% | −22.0% | −40.2% | −23.5% |
| Net income | $7.7M | −$106M | −$59.1M | −$82.2M | −$38.8M |
| Net margin | 1.3% | −28.7% | −19.3% | −35.9% | −18.2% |
| Diluted EPS | $0.02 | −$0.26 | −$0.15 | −$0.20 | −$0.09 |
| Cash | |||||
| Cash from operations | −$66.5M | −$180M | $6.9M | −$31.0M | $6.7M |
| Share count change | 5.4% | −0.3% | 1.6% | 0.8% | 1.0% |
| Debt and strength | |||||
| Cash and short-term investments | $454M | $309M | $321M | $294M | $303M |
| Debt incl. finance leases | $0.0M | — | — | — | — |
| Shareholders' equity | $667M | $595M | $552M | $486M | $459M |
| Net debt / EBITDA | −40.9x | — | — | — | — |
| Current ratio | 2.4x | 2.7x | 2.8x | 3.3x | 3.3x |
| Interest coverage | 81.4x | −7,057.9x | −8,448.5x | −13,113.9x | −7,167.1x |
| Returns and quality | |||||
| Return on capital | 3.4% | — | — | — | — |
| Return on equity | 1.2% | −16.8% | −10.3% | −15.8% | −8.2% |
| Return on tangible equity | 1.2% | −18.4% | −11.1% | −17.5% | −8.7% |
| Piotroski F-score | 3 | 2 | 4 | 2 | 5 |
| Altman Z'' | 0.6 | −1.1 | −1.0 | −2.3 | −2.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Amarin Corp Plc\Uk · AMRN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $12.09 a share, the company is worth $5.0B.
Source: SEC EDGAR XBRL filings (CIK 0000897448). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.